VICOR CORP

Previous wording

-17- impact of the steps taken to mitigate supply chain disruptions have, to varying degrees and at different times, reduced our revenue, gross margin, operating profit and cash flow and may continue to do so in the future. While we continue to make progress in moving outsourced manufacturing steps in-house to the Company, we are still experiencing long lead times on certain raw material components, and uncertainty of output from our outsourced manufacturing supplier. Our quarterly gross margin as a percentage of net revenues may vary, depending on production volumes, average selling prices, average unit costs, the mix of products sold during that quarter, and the level of importation of raw materials subject to tariffs. Our quarterly operating margin as a percentage of net revenues also may vary with changes in revenue and product level profitability, but our operating costs are largely associated with compensation and related employee costs, which are not subject to sudden or significant changes.

Current wording

-17- impact of the steps taken to mitigate supply chain disruptions have, to varying degrees and at different times, reduced our revenue, gross margin, operating profit and cash flow and may continue to do so in the future. Our quarterly gross margin as a percentage of net revenues may vary, depending on production volumes, average selling prices, average unit costs, the mix of products sold during that quarter, and the level of importation of raw materials subject to tariffs. Our quarterly operating margin as a percentage of net revenues also may vary with changes in revenue and product level profitability, but our operating costs are largely associated with compensation and related employee costs, which are not subject to sudden or significant changes.

Previous wording

Summary of Second Quarter 2024 Financial Performance Compared to First Quarter 2024 Financial Performance

Current wording

Summary of Third Quarter 2024 Financial Performance Compared to Second Quarter 2024 Financial Performance

Previous wording

The following summarizes our financial performance for the second quarter of 2024, compared to the first quarter of 2024:

Current wording

The following summarizes our financial performance for the third quarter of 2024, compared to the second quarter of 2024:

Previous wording

Net revenues increased 2.4% to $85,854,000 for the second quarter of 2024, from $83,872,000 for the first quarter of 2024. Net revenues for Brick Products decreased 2.7% compared to the first quarter of 2024, primarily due to reduced market demand. Advanced Products net revenues increased 7.1% compared to the first quarter of 2024, primarily due to reduced manufacturing constraints and increased royalty revenue in the second quarter of 2024.

Current wording

Net revenues increased 8.5% to $93,166,000 for the third quarter of 2024, from $85,854,000 for the second quarter of 2024. Net revenues for Brick Products increased 10.8% compared to the second quarter of 2024, primarily due to market demand. Advanced Products net revenues increased 6.5% compared to the second quarter of 2024, primarily due to increased royalty revenue in the third quarter of 2024.

Previous wording

Export sales represented approximately 43.3% of total net revenues in the second quarter of 2024 as compared to 42.6% in the first quarter of 2024.

Current wording

Export sales represented approximately 49.0% of total net revenues in the third quarter of 2024 as compared to 43.3% in the second quarter of 2024.

Previous wording

Gross margin decreased to $42,771,000 for the second quarter of 2024 from $45,123,000 for the first quarter of 2024, with gross margin, as a percentage of net revenues, decreasing to 49.8% for the second quarter of 2024 from 53.8% for the first quarter of 2024. The decrease in gross margin dollars and gross margin percentage was primarily attributable to the overall unfavorable sales mix on slightly higher sales volume in the second quarter of 2024, offset by production efficiencies and lower supply chain costs, including a reduction of freight-in and tariff spending of $1,041,000 (net of approximately $662,000 in duty drawback recovery in the second quarter of 2024 and $0 in duty drawback recovery in the first quarter of 2024 of previously paid tariffs).

Current wording

Gross margin increased to $45,744,000 for the third quarter of 2024 from $42,771,000 for the second quarter of 2024, with gross margin, as a percentage of net revenues, decreasing to 49.1% for the third quarter of 2024 from 49.8% for the second quarter of 2024. The increase in gross margin dollars was primarily the result of higher sales volume in the third quarter of 2024, including royalty revenue, with the decrease in gross margin percentage primarily attributable to unfavorable product mix and higher supply chain costs, including increased freight-in and tariff spending of $1,153,000 (net of approximately $56,000 in duty drawback recovery in the third quarter of 2024 and $662,000 in duty drawback recovery in the second quarter of 2024 of previously paid tariffs) offset by production efficiencies.

Previous wording

Backlog, which represents the total value of orders for products for which shipment is scheduled within the next 12 months, was approximately $153,794,000 at the end of the second quarter of 2024, as compared to $150,340,000 at the end of the first quarter of 2024.

Current wording

Backlog, which represents the total value of orders for products for which shipment is scheduled within the next 12 months, was approximately $150,590,000 at the end of the third quarter of 2024, as compared to $153,794,000 at the end of the second quarter of 2024.

Previous wording

Litigation-contingency expense was $2,300,000 for the second quarter of 2024 which related to the SynQor litigation, as compared to $0 for the second quarter of 2023. See Note 10 to the Condensed Consolidated Financial Statements for additional information.

Current wording

Operating expenses for the third quarter of 2024 decreased $2,199,000, or 5.2%, to $40,358,000 from $42,557,000 for the second quarter of 2024. Litigation-contingency expense related to the litigation with SynQor, Inc. ("SynQor") was $0 for the third quarter of 2024, compared to $2,300,000 for the second quarter of 2024. See Note 10 to the Condensed Consolidated Financial Statements for additional information regarding the litigation with SynQor.

Previous wording

We reported a net loss for the second quarter of 2024 of $(1,196,000), or $(0.03) per diluted share, compared to net income of $17,101,000, or $0.38 per diluted share, for the second quarter of 2023.

Current wording

We reported net income for the third quarter of 2024 of $11,552,000, or $0.26 per diluted share, compared to a net loss of $(1,196,000), or $(0.03) per diluted share, for the second quarter of 2024.

Previous wording

For the second quarter of 2024, depreciation and amortization totaled $4,661,000 and capital additions totaled $6,141,000 as compared to depreciation and amortization of $4,614,000 and capital additions of $7,270,000 for the first quarter of 2023.

Current wording

For the third quarter of 2024, depreciation and amortization totaled $4,741,000 and capital additions totaled $8,455,000 as compared to depreciation and amortization of $4,661,000 and capital additions of $6,141,000 for the second quarter of 2024.

Previous wording

Inventories decreased by approximately $3,232,000, or 2.9%, to $109,084,000 at June 30, 2024, compared to $112,316,000 at March 31, 2024.

Current wording

Inventories decreased by approximately $3,323,000, or 3.0%, to $105,761,000 at September 30, 2024, compared to $109,084,000 at June 30, 2024.

Previous wording

Net revenues for the second quarter of 2024 were $85,854,000, a decrease of $20,893,000, or 19.6%, as compared to $106,747,000 for the second quarter of 2023. Net revenues, by product line, for the three months ended June 30, 2024 and 2023 were as follows (dollars in thousands):

Current wording

Net revenues for the third quarter of 2024 were $93,166,000, a decrease of $14,678,000, or 13.6%, as compared to $107,844,000 for the third quarter of 2023. Net revenues, by product line, for the three months ended September 30, 2024 and 2023 were as follows (dollars in thousands):

Previous wording

The decrease in net revenues for Advanced Products was primarily due to our continued softness in underpenetrated markets, partially offset by increased royalty revenue in the quarter.

Current wording

The decrease in net revenues for Advanced Products was primarily due to continued softness in underpenetrated markets, partially offset by increased royalty revenue in the quarter. The decrease in net revenues for Brick Products was primarily due to reduced market demand.

Previous wording

Gross margin for the second quarter of 2024 decreased $12,402,000, or 22.5%, to $42,771,000, from $55,173,000 for the second quarter of 2023. Gross margin, as a percentage of net revenues, decreased to 49.8% for the second quarter of 2024, compared to 51.7% for the second quarter of 2023. The decrease in gross margin dollars and gross margin percentage was primarily attributable to lower sales volume and to a lesser extent an unfavorable sales mix on that sales volume, offset by higher royalty revenue and production efficiencies and supply chain costs, including a reduction of $782,000 in outsourced manufacturing costs partially offset by incremental costs of bringing production in-house for certain Advanced Products, and an increase in freight-in and tariff spending of $710,000 (net of approximately $662,000 in duty drawback recovery in the second quarter of 2024 and $2,750,000 in duty drawback recovery in the second quarter of 2023 of previously paid tariffs).

Current wording

Gross margin for the third quarter of 2024 decreased $10,134,000, or 18.1%, to $45,744,000, from $55,878,000 for the third quarter of 2023. Gross margin, as a percentage of net revenues, decreased to 49.1% for the third quarter of 2024, compared to 51.8% for the third quarter of 2023. The decrease in gross margin dollars and gross margin percentage was primarily attributable to lower sales volume and unfavorable sales mix on that volume, offset by higher royalty revenue and improved production efficiencies and supply chain costs, including lower freight-in and tariff spending of $430,000 (net of approximately $56,000 in duty drawback recovery in the third quarter of 2024 and $0 in duty drawback recovery in the third quarter of 2023 of previously paid tariffs).

Previous wording

Selling, general and administrative expenses were $23,318,000 for the second quarter of 2024, an increase of $2,943,000, or 14.4%, from $20,375,000 for the second quarter of 2023. Selling, general and administrative expenses as a percentage of net revenues increased to 27.2% for the second quarter of 2024 from 19.1% for the second quarter of 2023. The components of the $2,943,000 increase in selling, general and administrative expenses for the second quarter of 2024 from the second quarter of 2023 were as follows (dollars in thousands):

Current wording

Selling, general and administrative expenses were $23,398,000 for the third quarter of 2024, an increase of $976,000, or 4.4%, from $22,422,000 for the third quarter of 2023. Selling, general and administrative expenses as a percentage of net revenues increased to 25.1% for the third quarter of 2024 from 20.8% for the third quarter of 2023. The components of the $976,000 increase in selling, general and administrative expenses for the third quarter of 2024 from the third quarter of 2023 were as follows (dollars in thousands):

Previous wording

Increase primarily attributable to an increase in activity related to corporate legal matters, asserting our intellectual property rights.

Current wording

Increase primarily attributable to an increase in activity related to corporate legal matters, including the assertion of our intellectual property rights.

Previous wording

Increase primarily attributable to higher stock-based compensation expense associated with stock options awarded in May 2024 and an increase in fringe benefits accruals.

Current wording

Increase primarily attributable to higher stock-based compensation expense associated with stock options awarded in May 2024.

Previous wording

Research and development expenses were $16,939,000 for the second quarter of 2024, an increase of $4,000, or 0.0%, compared to $16,935,000 for the second quarter of 2023. As a percentage of net revenues, research and development expenses increased to 19.7% for the second quarter of 2024 from 15.9% for the second quarter of 2023.

Current wording

Research and development expenses were $16,960,000 for the third quarter of 2024, a decrease of $792,000, or 4.5%, compared to $17,752,000 for the third quarter of 2023. As a percentage of net revenues, research and development expenses increased to 18.2% for the third quarter of 2024 from 16.5% for the third quarter of 2023. The components of the $792,000 decrease in research and development expenses for the third quarter of 2024 from the third quarter of 2023 were as follows (dollars in thousands):

Previous wording

Our exposure to market risk fluctuations in foreign currency exchange rates relates to the operations of Vicor Japan Company, Ltd. (“VJCL”), for which the functional currency is the Japanese Yen, and all other subsidiaries in Europe and Asia, for which the functional currency is the U.S. Dollar. These subsidiaries in Europe and Asia experienced less unfavorable foreign currency exchange rate fluctuations in the second quarter of 2024 compared to the second quarter of 2023. Interest income for the three months ended June 30, 2024 increased due to higher balances of cash and cash equivalents held by the Company.

Current wording

Our exposure to market risk fluctuations in foreign currency exchange rates relates to the operations of Vicor Japan Company, Ltd. (“VJCL”), for which the functional currency is the Japanese Yen, and all other subsidiaries in Europe and Asia, for which the functional currency is the U.S. Dollar. These subsidiaries in Europe and Asia experienced favorable foreign currency exchange rate fluctuations in the third quarter of 2024 compared to the third quarter of 2023. Interest income for the three months ended September 30, 2024 increased due to higher balances of cash and cash equivalents held by the Company.

Previous wording

Income before income taxes was $3,021,000 for the second quarter of 2024, as compared to $19,639,000 for the second quarter of 2023.

Current wording

Income before income taxes was $9,099,000 for the third quarter of 2024, as compared to $17,621,000 for the third quarter of 2023.

Previous wording

The provision for income taxes and the effective income tax rates for the three months ended June 30, 2024 and 2023 were as follows (dollars in thousands):

Current wording

The (benefit) provision for income taxes and the effective income tax rates for the three months ended September 30, 2024 and 2023 were as follows (dollars in thousands):

Previous wording

The effective tax rates differ from the statutory tax rates for the three months ended June 30, 2024 and 2023 primarily due to the Company’s full valuation allowance position against domestic deferred tax assets. The provision for income taxes for the three months ended June 30, 2024 and 2023 included estimated federal, state and foreign income taxes in jurisdictions in which the Company does not have sufficient tax attributes.

Current wording

The effective tax rates differ from the statutory tax rates for the three months ended September 30, 2024 and 2023 primarily due to the Company’s full valuation allowance position against domestic deferred tax assets. The (benefit) provision for income taxes for the three months ended September 30, 2024 and 2023 included estimated federal, state and foreign income taxes in jurisdictions in which the Company does not have sufficient tax attributes.

Previous wording

The Company’s tax expense and the rate for the quarter continues to be negatively impacted by the capitalization of research and development expenses under Section 174 in the U.S., which given the Company’s close to breakeven performance, is having an outsized impact on the rate by effectively moving from a book loss to a taxable income position, which causes a significant tax expense. This is further compounded by the Company not getting a deferred tax benefit from temporary differences due to the full valuation allowance on domestic deferred tax assets.

Current wording

The Company’s tax expense and rate for the three months ended September 30, 2024 continues to be negatively impacted by the capitalization of research and development expenses under Section 174 in the U.S., which given the Company’s close to breakeven performance, is having an outsized impact on the rate by effectively moving from a book loss to a taxable income position, which causes a significant tax expense. This is further compounded by the Company not recording a deferred tax benefit from temporary differences due to the full valuation allowance on domestic deferred tax assets.

Previous wording

Net revenues for the six months ended June 30, 2024 were $169,726,000, a decrease of $34,837,000, or 17.0%, from $204,563,000 for the six months ended June 30, 2023. Net revenues, by product line, for the six months ended June 30, 2024 and the six months ended June 30, 2023 were as follows (dollars in thousands):

Current wording

Net revenues for the nine months ended September 30, 2024 were $262,892,000, a decrease of $49,515,000, or 15.8%, from $312,407,000 for the nine months ended September 30, 2023. Net revenues, by product line, for the nine months ended September 30, 2024 and the nine months ended September 30, 2023 were as follows (dollars in thousands):

Previous wording

Gross margin for the six months ended June 30, 2024 decreased $13,813,000, or 13.6%, to $87,894,000 from $101,707,000 for the six months ended June 30, 2023. Gross margin, as a percentage of net revenues, increased to 51.8% for the six month period ended June 30, 2024, as compared to 49.7% for the six month period ended June 30, 2023. The decrease in gross margin dollars was primarily the result of lower sales volume in the first six months of 2024, with the increase in gross margin percentage primarily attributable to improved sales mix on that volume, including royalty revenue, compared to the first six months of 2023 and certain reductions in supply chain costs, including a reduction of $1,967,000 in outsourced manufacturing costs partially offset by incremental costs of bringing production in-house for certain Advanced Products, and an increase in freight-in and tariff spending of $1,932,000 (net of approximately $662,000 in duty drawback recovery in the first six months of 2024 and $5,715,000 in duty drawback recovery in the first six months of 2023 of previously paid tariffs).

Current wording

Gross margin for the nine months ended September 30, 2024 decreased $23,947,000, or 15.2%, to $133,638,000 from $157,585,000 for the nine months ended September 30, 2023. Gross margin, as a percentage of net revenues, increased to 50.8% for the nine-month period ended September 30, 2024, as compared to 50.4% for the nine-month period ended September 30, 2023. The decrease in gross margin dollars was primarily the result of lower sales volume in the first nine months of 2024, with the increase in gross margin percentage primarily attributable to higher royalty revenue and improved production efficiencies compared to the first nine months of 2023 along with certain reductions in supply chain costs, including a reduction of $2,108,000 in outsourced manufacturing costs partially offset by incremental costs of bringing production in-house for certain Advanced Products, offset by slightly unfavorable sales mix and an increase in freight-in and tariff spending of $1,502,000 (net of approximately $717,000 in duty drawback recovery in the first nine months of 2024 and $5,715,000 in duty drawback recovery in the first nine months of 2023 of previously paid tariffs).

Previous wording

Selling, general and administrative expenses were $49,317,000 for the six months ended June 30, 2024, an increase of $8,719,000, or 21.5%, compared to $40,598,000 for the six months ended June 30, 2023. Selling, general and administrative expenses as a percentage of net revenues increased to 29.1% for the six months ended June 30, 2024 from 19.8% for the six months ended June 30, 2023. The components of the $8,719,000 increase in selling, general and administrative expenses for the six months ended June 30, 2024 compared to the six months ended June 30, 2023 were as follows (dollars in thousands):

Current wording

Selling, general and administrative expenses were $72,715,000 for the nine months ended September 30, 2024, an increase of $9,695,000, or 15.4%, compared to $63,020,000 for the nine months ended September 30, 2023. Selling, general and administrative expenses as a percentage of net revenues increased to 27.7% for the nine months ended September 30, 2024 from 20.2% for the nine

Previous wording

Increase primarily attributable to an increase in activity related to corporate legal matters, asserting our intellectual property rights.

Current wording

Increase primarily attributable to an increase in activity related to corporate legal matters, including the assertion of our intellectual property rights.

Previous wording

Research and development expenses were $34,978,000 for the six months ended June 30, 2024, an increase of $2,174,000, or 6.6%, from $32,804,000 for the six months ended June 30, 2023. As a percentage of net revenues, research and development expenses increased to 20.6% for the six months ended June 30, 2024 from 16.0% for the six months ended June 30, 2023. The components of

Current wording

Research and development expenses were $51,938,000 for the nine months ended September 30, 2024, an increase of $1,382,000, or 2.7%, from $50,556,000 for the nine months ended September 30, 2023. As a percentage of net revenues, research and development expenses increased to 19.8% for the nine months ended September 30, 2024 from 16.2% for the nine months ended September 30, 2023. The components of the $1,382,000 increase in research and development expenses for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 were as follows (dollars in thousands):

Previous wording

Litigation-contingency expense was $19,500,000 for the six months ended June 30, 2024 which related to the SynQor litigation, as compared to $0 for the six months ended June 30, 2023. See Note 10 to the Condensed Consolidated Financial Statements for additional information regarding the SynQor litigation.

Current wording

Litigation-contingency expense was $19,500,000 for the nine months ended September 30, 2024 which related to the SynQor litigation, as compared to $0 for the nine months ended September 30, 2023. See Note 10 to the Condensed Consolidated Financial Statements for additional information regarding the SynQor litigation.

Previous wording

The significant components of ''Other income (expense), net'' for the six months ended June 30, 2024 and the six months ended June 30, 2023 and the changes from period to period were as follows (in thousands):

Current wording

The significant components of ''Other income (expense), net'' for the nine months ended September 30, 2024 and the nine months ended September 30, 2023 and the changes from period to period were as follows (in thousands):

Previous wording

Our exposure to market risk fluctuations in foreign currency exchange rates relates to the operations of VJCL, for which the functional currency is the Japanese Yen, and all other subsidiaries in Europe and Asia, for which the functional currency is the U.S. Dollar. These subsidiaries in Europe and Asia experienced more unfavorable foreign currency exchange rate fluctuations in the first six months of 2024 compared to the first six months of 2023. Interest income for the six months ended June 30, 2024 increased due to higher balances of cash and cash equivalents held by the Company.

Current wording

Our exposure to market risk fluctuations in foreign currency exchange rates relates to the operations of VJCL, for which the functional currency is the Japanese Yen, and all other subsidiaries in Europe and Asia, for which the functional currency is the U.S. Dollar. These subsidiaries in Europe and Asia experienced less unfavorable foreign currency exchange rate fluctuations in the first nine months of 2024 compared to the first nine months of 2023. Interest income for the nine months ended September 30, 2024 increased due to higher balances of cash and cash equivalents held by the Company.

Previous wording

Income (loss) before income taxes was $(10,370,000) for the six months ended June 30, 2024, as compared to $32,031,000 for the six months ended June 30, 2023.

Current wording

(Loss) income before income taxes was $(1,271,000) for the nine months ended September 30, 2024, as compared to $49,652,000 for the nine months ended September 30, 2023.

Previous wording

The provision for income taxes and the effective income tax rates for the six months ended June 30, 2024 and 2023 were as follows (dollars in thousands):

Current wording

The provision for income taxes and the effective income tax rates for the nine months ended September 30, 2024 and 2023 were as follows (dollars in thousands):

Previous wording

The effective tax rates differ from the statutory tax rates for the six months ended June 30, 2024 and 2023 primarily due to the Company’s full valuation allowance position against domestic deferred tax assets. The provision for income taxes for the six months ended June 30, 2024 and 2023 included estimated federal, state and foreign income taxes in jurisdictions in which the Company does not have sufficient tax attributes.

Current wording

The effective tax rates differ from the statutory tax rates for the nine months ended September 30, 2024 and 2023 primarily due to the Company’s full valuation allowance position against domestic deferred tax assets. The provision for income taxes for the nine months ended September 30, 2024 and 2023 included estimated federal, state and foreign income taxes in jurisdictions in which the Company does not have sufficient tax attributes.

Previous wording

The Company’s tax expense and the rate for the six months ended June 30, 2024 continues to be negatively impacted by the capitalization of research and development expenses under Section 174 in the U.S., which given the Company’s six month performance, is having an outsized impact on the rate by effectively moving from a book loss to a taxable income position, which causes a significant tax expense. This is further compounded by the Company not getting a deferred tax benefit from temporary differences due to the full valuation allowance on domestic deferred tax assets.

Current wording

The Company's tax expense and the rate for the nine months ended September 30, 2024 continues to be negatively impacted by the capitalization of research and development expenses under Section 174 in the U.S., which given the Company's nine month performance, is having an outsized impact on the rate by effectively moving from a book loss to a taxable income position, which causes a significant tax expense. This is further compounded by the Company not getting a deferred tax benefit from temporary differences due to the full valuation allowance on domestic deferred tax assets.

Previous wording

We reported a net loss for the six months ended June 30, 2024 of $(15,669,000), or $(0.35) per diluted share, as compared to net income of $28,345,000, or $0.63 per diluted share, for the six months ended June 30, 2023.

Current wording

We reported a net loss for the nine months ended September 30, 2024 of $(4,117,000), or $(0.09) per diluted share, as compared to net income of $44,927,000, or $1.00 per diluted share, for the nine months ended September 30, 2023.

Previous wording

As of June 30, 2024, we had $251,884,000 in cash and cash equivalents. The ratio of total current assets to total current liabilities was 6.4:1 as of June 30, 2024 and 9.5:1 as of December 31, 2023. Working capital, defined as total current assets less total current liabilities, decreased $8,698,000 to $367,499,000 as of June 30, 2024 from $376,197,000 as of December 31, 2023.

Current wording

As of September 30, 2024, we had $267,605,000 in cash and cash equivalents. The ratio of total current assets to total current liabilities was 6.4:1 as of September 30, 2024 and 9.5:1 as of December 31, 2023. Working capital, defined as total current assets less total current liabilities, increased $4,256,000 to $380,453,000 as of September 30, 2024 from $376,197,000 as of December 31, 2023.

Previous wording

The primary sources of cash for the six months ended June 30, 2024 were $18,148,000 generated from operations, and $5,138,000 received in connection with the exercise of options to purchase our Common Stock awarded under our stock option plans and the issuance of Common Stock under our 2017 Employee Stock Purchase Plan. The primary uses of cash during the six months ended June 30, 2024 were for the purchase of property and equipment of $13,411,000.

Current wording

The primary sources of cash for the nine months ended September 30, 2024 were $40,725,000 generated from operations and $7,047,000 received in connection with the exercise of options to purchase our Common Stock awarded under our stock option plans and the issuance of Common Stock under our 2017 Employee Stock Purchase Plan. The primary uses of cash during the nine months ended September 30, 2024 were for the purchase of property and equipment of $21,866,000.

Previous wording

In July 2024, our Board of Directors authorized the repurchase of up to $100,000,000 of our Common Stock (the “New Repurchase Authorization”). The New Repurchase Authorization replaces the November 2000 Plan in its entirety and no further repurchases will be made pursuant to the November 2000 Plan. See Note 12 to the Condensed Consolidated Financial Statements for additional information.

Current wording

In November 2000, our Board of Directors authorized the repurchase of up to $30,000,000 of our Common Stock (the “November 2000 Plan”). In July 2024, our Board of Directors authorized the repurchase of up to $100,000,000 of our Common Stock (the “New Repurchase Authorization”). The New Repurchase Authorization replaces the November 2000 Plan in its entirety and no further repurchases will be made pursuant to the November 2000 Plan. As of September 30, 2024, we had approximately $99,503,000 remaining available for repurchases of our Common Stock under the New Repurchase Authorization.

Previous wording

As of June 30, 2024, we had a total of approximately $14,986,000 of cancelable and non-cancelable capital expenditure commitments, principally for manufacturing and production equipment, which we intend to fund with existing cash, and approximately $2,133,000 of capital expenditure items and internal-use software which had been received and included in Property, plant and equipment, net in the accompanying Condensed Consolidated Balance Sheets, but not yet paid for. Our primary needs for liquidity are for making continuing investments in manufacturing and production equipment. We believe cash generated from operations together with our available cash and cash equivalents will be sufficient to fund planned operational needs and capital equipment purchases, for both the short and long term.

Current wording

As of September 30, 2024, we had a total of approximately $14,073,000 of cancelable and non-cancelable capital expenditure commitments, principally for manufacturing and production equipment, which we intend to fund with existing cash, and approximately $2,976,000 of capital expenditure items and internal-use software which had been received and included in Property, plant and equipment, net in the accompanying Condensed Consolidated Balance Sheets, but not yet paid for. Our primary needs for liquidity are for making continuing investments in manufacturing and production equipment. We believe cash generated from operations together with our available cash and cash equivalents will be sufficient to fund planned operational needs and capital equipment purchases, for both the short and long term.